Evidence map›Paper›PMID 34066325›Full record

ReviewCancers2021

Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class-A Meta-Analysis.

Anthony B Daniels, Shriji N Patel, Ronald W Milam, Sahar Kohanim, Debra L Friedman, Tatsuki Koyama

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Update on Retinoblastoma Therapies.Medicina (Kaunas, Lithuania) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Indocyanine green-enhanced transpupillary thermotherapy in treatment of retinoblastoma: Experience in Indian eyes.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Anthony B DanielsDepartment of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Shriji N PatelDepartment of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Ronald W MilamDepartment of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Sahar KohanimDepartment of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Debra L FriedmanDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Tatsuki KoyamaVanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Vanderbilt University Medical Center · US

Funding

Developing alternative approaches to reduce retinal toxicity and prevent vision loss in the treatment of intraocular retinoblastomaK08EY027464 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DANIELS, ANTHONY BRENT · 2017 to 2021
$960k
NEI NIH HHS NIH/NEI K08EY027464Research to Prevent Blindness Career Development Award and Unrestricted Grant to the Vanderbilt Department of Ophthalmology
6 · The paper itself

Abstract

To evaluate the relative efficacy of novel retinoblastoma treatments, eye classification-specific success rates for current standard-of-care intravenous chemotherapy regimens must be known. This meta-analysis included studies if: (1) patients received intravenous chemotherapy for retinoblastoma, (2) globe salvage data was reported, (3) only

Indexed as

globe salvage ratesinternational classification of retinoblastomaintra-arterial chemotherapyintravenous chemotherapyintravitreal chemotherapyradiotherapyReese–Ellsworth classificationretinoblastoma

Identifiers

PMID34066325
PMCPMC8125212
OpenAlexW3157450189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.